Navigation Links
DATATRAK Receives CDISC Registered Solutions Provider Status
Date:12/6/2011

CLEVELAND, Dec. 6, 2011  /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced it was recognized as a CDISC Registered Solutions Provider.  DATATRAK has been registered as a CDISC consultant, system integrator and subject matter expert in the following CDISC standards:

CDASH – Clinical Data Acquisition Standards Harmonization
LAB – Laboratory Data Model
ODM – Operational Data Model
SDTM – Study Data Tabulation Model

"As a leader in eClinical solutions, standards play a very important role in our acceleration of drug development timelines," stated Laurence P. Birch, DATATRAK's Chairman of the Board and CEO. "Our CDISC Registered Solutions Provider status officially recognizes our internal practices and strengthens our involvement in the global effort to improve efficiencies in clinical research."

About CDISC
CDISC is a global, open, multidisciplinary, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data and metadata. For more information on CDISC, please see http://www.cdisc.org.

About DATATRAK
DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE™ software so
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DATATRAK Announces Expanded DATATRAK ONE™ Product Suite
2. DATATRAK Exhibiting at 47th Annual DIA Meeting
3. DATATRAK to Attend DIAs 23rd Annual EuroMeeting
4. DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2010
5. DATATRAK Awarded First Study With Kreara Solutions
6. DATATRAK Awarded Three Phase III Studies
7. DATATRAK Secures Safe Harbor Certification for EU and Switzerland
8. DATATRAK Premieres Safety System at DIA
9. DATATRAK Attends 22nd Annual DIA EuroMeeting in Monaco
10. DATATRAK International and PFC Pharma Focus to Co-Sponsor eClinical Solutions Seminar in Tel Aviv
11. DATATRAK Attends 13th Annual DIA Workshop in Japan for Clinical Data Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... , July 25, 2014 Research and ... "Global Ophthalmic Diagnostic Devices Market 2014-2018" report to ... About Ophthalmic Diagnostic Device ... to identify a defect or deficiency in the human ... ophthalmic disorders such as presbyopia, cataracts, glaucoma, retinal disorders, ...
(Date:7/25/2014)... NORTH CHICAGO, Ill., July 25, 2014 ... PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION ... RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION AbbVie (NYSE: ... quarter ended June 30, 2014. "This was ... and earnings per share above our original guidance and announced ...
(Date:7/24/2014)... PLAINFIELD, N.J. , July 24, 2014  PTC ... that the Company will host a webcast conference call ... provide an update on the company,s business and outlook ... before the opening of the market. ... (domestic) or (973) 935-8152 (international) five minutes prior to ...
Breaking Medicine Technology:Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2AbbVie Reports Second-Quarter 2014 Financial Results 2AbbVie Reports Second-Quarter 2014 Financial Results 3AbbVie Reports Second-Quarter 2014 Financial Results 4AbbVie Reports Second-Quarter 2014 Financial Results 5AbbVie Reports Second-Quarter 2014 Financial Results 6AbbVie Reports Second-Quarter 2014 Financial Results 7AbbVie Reports Second-Quarter 2014 Financial Results 8AbbVie Reports Second-Quarter 2014 Financial Results 9AbbVie Reports Second-Quarter 2014 Financial Results 10AbbVie Reports Second-Quarter 2014 Financial Results 11AbbVie Reports Second-Quarter 2014 Financial Results 12AbbVie Reports Second-Quarter 2014 Financial Results 13AbbVie Reports Second-Quarter 2014 Financial Results 14AbbVie Reports Second-Quarter 2014 Financial Results 15AbbVie Reports Second-Quarter 2014 Financial Results 16AbbVie Reports Second-Quarter 2014 Financial Results 17AbbVie Reports Second-Quarter 2014 Financial Results 18AbbVie Reports Second-Quarter 2014 Financial Results 19AbbVie Reports Second-Quarter 2014 Financial Results 20AbbVie Reports Second-Quarter 2014 Financial Results 21AbbVie Reports Second-Quarter 2014 Financial Results 22AbbVie Reports Second-Quarter 2014 Financial Results 23AbbVie Reports Second-Quarter 2014 Financial Results 24AbbVie Reports Second-Quarter 2014 Financial Results 25AbbVie Reports Second-Quarter 2014 Financial Results 26AbbVie Reports Second-Quarter 2014 Financial Results 27AbbVie Reports Second-Quarter 2014 Financial Results 28AbbVie Reports Second-Quarter 2014 Financial Results 29AbbVie Reports Second-Quarter 2014 Financial Results 30AbbVie Reports Second-Quarter 2014 Financial Results 31AbbVie Reports Second-Quarter 2014 Financial Results 32AbbVie Reports Second-Quarter 2014 Financial Results 33AbbVie Reports Second-Quarter 2014 Financial Results 34AbbVie Reports Second-Quarter 2014 Financial Results 35
... Actavis Group, the international generic pharmaceuticals company, ... US Food & Drug Administration to market Losartan Potassium ... 25 mg, 50 mg and 100 mg strength.  Losartan ... Iceland. Losartan Potassium Tablets, USP had US ...
... 12 WPI Holdings d/b/a Woodbury Health Products ("Woodbury"), ... announced today that it has completed the acquisition of ... Wilmington, North Carolina and founded in 1993, WMS is ... focused on urological catheters and sterile kits.  With a ...
Cached Medicine Technology:Actavis Receives Approval of Losartan Potassium Tablets, USP in the U.S. 2WPI Holdings Acquires Wilmington Medical Supply Inc. 2
(Date:7/27/2014)... BC (PRWEB) July 27, 2014 Prominent ... recently announced their demonstration depicting the hamstring release procedure ... in Action Wellness Center in Vancouver and have years ... hamstring release procedure was carried out by the two ... purpose of the exercise is to release tight hamstrings ...
(Date:7/27/2014)... TX (PRWEB) July 27, 2014 ... on Global and Chinese Dutasteride (CAS 164656-23-9) industry. ... Dutasteride (CAS 164656-23-9) including its classification, application and ... China’s top manufacturers of Dutasteride (CAS 164656-23-9) listing ... share etc. , The report further analyzes quantitatively ...
(Date:7/27/2014)... (PRWEB) July 27, 2014 The European ... market in Europe with analysis and forecast of revenue. ... grow from around $509.4 million in 2013 to $657.1 ... 2013 to 2018. , Browse through the TOC of ... idea of the in-depth analysis provided. It also provides ...
(Date:7/27/2014)... 2014 The European Bromine market report defines ... forecast of revenue. , Bromine market in European region comprises ... UK. Germany and France that forms a dominant share of ... in Europe. , Browse through the TOC of the ... in-depth analysis provided Browse through the TOC of the Europe ...
(Date:7/27/2014)... (PRWEB) July 27, 2014 Although ... Australia is restricted to two companies, heavy government ... IBISWorld industry analyst Spencer Little, “Demand for cigarettes ... to rising health concerns, frequent anti-smoking campaigns, increasing ... industry revenue is estimated to fall at a ...
Breaking Medicine News(10 mins):Health News:Renowned Vancouver Chiropractors Demonstrates Hamstring Release in Vancouver, BC 2Health News:Global and Chinese Dutasteride Industry (CAS 164656-23-9) 2019 Forecasts in New Research Report at ReportsnReports.com 2Health News:Global and Chinese Dutasteride Industry (CAS 164656-23-9) 2019 Forecasts in New Research Report at ReportsnReports.com 3Health News:Global and Chinese Dutasteride Industry (CAS 164656-23-9) 2019 Forecasts in New Research Report at ReportsnReports.com 4Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Bromine Market is Expected to Reach $111.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Bromine Market is Expected to Reach $111.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Bromine Market is Expected to Reach $111.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Cigarette and Tobacco Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Cigarette and Tobacco Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Cigarette and Tobacco Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4
... Results on Preoperative Chemotherapy in Early Breast Cancer ... than six cycles in women with early breast cancer ... data from a randomized controlled trial. Additionally, women who ... one drug combination did not benefit from switching to ...
... California Long-Term Care Reimbursement Act of 2004 increased nursing home ... according to a UCSF evaluation on the legislations impact. , ... homes increased by $590 million, or nearly 9 percent, to ... study, which was released today by researchers in the UCSF ...
... and shipping regions may be markedly worse than previously ... and shipping pollution is exacerbated when it combines with ... published in this weeks advance online edition of the ... University of Calgary chemistry professor Hans Osthoff report that ...
... is prevalent among people living with chronic diseases, such ... live normal lives, they must manage symptoms and treatments ... daily basis. Now, researchers from two universities have found ... their symptoms of depression and improve the overall quality ...
... 2008 Marianjoy has,recently named two new Vice ... Pyrcik is the new Vice President and the ... responsible for the planning and,implementation of all fundraising ... giving, major and planned giving,special events and special ...
... ... Contracted Contrast Media, WAYNE, N.J., April 8, ... announced today that,the company has been awarded a two-year contract ... injection available to members of the Amerinet network., Amerinet ...
Cached Medicine News:Health News:Other highlights in the April 8 JNCI 2Health News:Other highlights in the April 8 JNCI 3Health News:Other highlights in the April 8 JNCI 4Health News:2004 long-term care act raised costs and worsened care, study shows 2Health News:2004 long-term care act raised costs and worsened care, study shows 3Health News:Sea salt worsens coastal air pollution: study 2Health News:Increasing positive experiences decreases depression symptoms in patients with multiple sclerosis 2Health News:Marianjoy Names Two Vice Presidents 2Health News:Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement 2Health News:Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement 3Health News:Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement 4
TBR-720-2-GD is large capacity upright style operating temperature +4C. It is specially designed refrigerators for the storage of blood in standard 500ml bags, complying with Australian Standard AS38...
DSL-10-49300 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in saliva. This assay requires no sample extraction or pretreat...
... Only 1-2% of circulating testosterone exists as ... 60%, is bound to SHBG with high ... bound to albumin. Both the albumin-bound and ... SHBG effectively inhibits testosterone action. Measurement of ...
RIA kit for the quantitative determination of autoantibodies to steroid 21-hydroxylase (21-OH) in serum....
Medicine Products: